| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| seribantumab | erbb3 tyrosine kinase receptor | NA | Clinical trial target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Cancer of Head and Neck[MeSHID:D006258] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.41 | phase 2 | antibody |
| seribantumab | erbb3 tyrosine kinase receptor | NA | Clinical trial target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Cancer of Head and Neck[MeSHID:D006258] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.41 | phase 2 | unknown |
| click here to return to the previous page | ||||||||